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Human mesenchymal stem cells stimulate EaHy926 
endothelial cell migration: combined proteomic and in vitro 
analysis of the influence of donor-donor variability 
 
 
Introduction 
Many potential therapies for severe and/or chronic wounds fail 
as a result of poor vasculature
[1]
. Hence, strategies to improve 
blood vessel supply into a wound bed are thought to promote 
wound healing. Transplantations of mesenchymal stem cells 
(MSCs) have shown great potential as a therapeutic agent for 
the treatment of a range of disorders, including wound 
healing, and have become the subject of numerous clinical 
trials
[2]
. However, whilst the safety of MSC transplantation 
does not seem to be an issue
[3, 4]
, the effectiveness of such 
treatment has exhibited considerable variability. This variation 
in effect is problematic when translating preclinical research 
into MSC-based clinical therapy. 
 
We recently demonstrated that human MSC-conditioned 
medium (MSC-CM) was stimulatory to epidermal and 
fibroblast cell adherence and migration
[5]
. Other reports 
suggest that MSC are pro-angiogenic also through their 
paracrine activity on endothelial cells
[6, 7]
. Whilst there are 
reports that MSC are capable of endothelial differentiation
[8,9]
, 
engraftment into new vasculature is low in vivo
[10,11]
. Hence, 
these and other studies have contributed to recent thought 
that the predominant regenerative activity of MSCs is due to 
their secretion of factors that stimulate endogenous cells at 
wound sites.  
 
In this investigation, we have examined the effects of MSC- 
CM on endothelial cells, using the cell line EaHy-926 as a  
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Mesenchymal stem cells (MSCs) stimulate angiogenesis within a wound environment and this effect is mediated through 
paracrine interactions with the endothelial cells present. Here we report that human MSC-conditioned medium (n=3 donors) 
significantly increased EaHy-926 endothelial cell adhesion and cell migration, but that this stimulatory effect was markedly donor-
dependent. MALDI-TOF/TOF mass spectrometry demonstrated that whilst collagen type I and fibronectin were secreted by all of 
the MSC cultures, the small leucine rich proteoglycan, decorin was secreted only by the MSC culture that was least effective upon 
EaHy-926 cells. These individual extracellular matrix components were then tested as culture substrata. EaHy-926 cell adherence 
was greatest on fibronectin-coated surfaces with least adherence on decorin-coated surfaces. Scratch wound assays were used 
to examine cell migration. EaHy-926 cell scratch wound closure was quickest on substrates of fibronectin and slowest on decorin. 
However, EaHy-926 cell migration was stimulated by the addition of MSC-conditioned medium irrespective of the types of culture 
substrates. These data suggest that whilst the MSC secretome may generally be considered angiogenic, the composition of the 
secretome is variable and this variation probably contributes to donor-donor differences in activity. Hence, screening and 
optimizing MSC secretomes will improve the clinical effectiveness of pro-angiogenic MSC-based therapies. 
 
 
model system
[12]
. We report that MSC-CM promotes endothelial 
cell adhesion and migration, but that these effects show 
considerable donor-donor variability. Further, we have identified 
extracellular matrix (ECM) proteins that are secreted by MSCs 
using MALDI/TOF-TOF mass spectrometry. We provide data to 
suggest that ECM composition plays a major role in the donor-
donor variation we have seen. These findings demonstrate proof 
of principle of the need to screen the MSC secretome in order to 
optimise the application of MSCs in the clinic. 
 
Methods 
 
Cell culture and mass spectrometry of conditioned medium 
 
EaHy-926 endothelial cells were maintained in DMEM/F12 
culture medium (Invitrogen, Paisley, UK) supplemented with 
10% (v/v) fetal calf serum (FCS) (Invitrogen) and 1% (v/v) 
penicillin and streptomycin (Invitrogen), incubated at 37°C and 
in a humidified atmosphere containing 5% (v/v) CO2. Passaging 
was performed at ~90% confluence and cells were re-seeded at 
1 x 10
4
 cells/cm
2
. MSCs were isolated from the iliac crest 
biopsies of bone marrow donors following ethical approval and 
with informed consent, as previously described
[13]
. The adherent 
cell population obtained was consistent with the characteristics 
of MSCs laid out by the International Society for Cellular 
Therapy (ISCT)
[14]
. Conditioned medium was generated from 
MSC cultures of equal cell number in serum free 
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conditions, using DMEM/F12 supplemented with insulin, 
transferrin and selenium (Invitrogen). Protein content of MSC 
CM was determined by MALDI-TOF/TOF mass spectrometry 
as previously described
[5]
. 
 
Characterization of MSC 
 
After three passages in culture, bone marrow derived cells 
were assessed by immunoprofiling for CD markers and by 
examining their differentiation potential to form osteoblasts, 
adipocytes and chondrocytes, by staining with alkaline 
phosphatase, oil red O, and toluidine blue respectively as per 
the criteria established for a MSC phenotype by the ISCT
[14]
.  
 
Coating of culture plates 
 
Culture plates were coated with MSC-CM or type-I collagen, 
decorin, or fibronectin (all Sigma-Aldrich). Protein solutions 
were diluted in PBS to 0.2mg/ml and added to each well (50µl 
for 96-well plates, 500µl for 24-well plates). These were 
refrigerated for 24 hours before being rinsed with PBS 
immediately prior to use. 
 
Cell adherence/spreading 
 
Coated 24-well tissue culture plates were seeded with 2x10
5
 
EaHy-926 endothelial cells in DMEM/F12 supplemented with 
1% penicillin/streptomycin (Sigma-Aldrich) and 1% ITS-X 
(Sigma-Aldrich) and incubated for 2 hours at 37°C and 5% 
CO2  before digital images were captured (ProgRes CF, 
Jenoptik) and analysed using Image-J software.  
 
Scratch-wound assays 
 
Scratch assays were established using previously published 
methods
[5]
,   in    protein-coated    tissue   culture   plates  (as 
described above).  Cell migration was automatically captured  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and analysed at hourly intervals using an Incucyte
TM
 Live-
Cell Imaging System (Essen Bioscience). 
 
Statistical analysis 
 
Data is presented as means (± SEM). Data were tested for 
significance using the Mann-Whitney U test. Those 
differences that fell within a 95%, 99% or 99.9% confidence 
interval were considered to be significant, indicated by 
asterisks within Figures (* p<0.05 ** p<0.01 *** p<0.001). 
 
Results 
 
Bone marrow cells obtained from iliac crest biopsies showed 
characteristics consistent with those expected of                    
MSC (Figure 1). MSC-CM coating of culture plates resulted 
in the significant enhancement of the spreading of EaHy-926 
endothelial cells upon the culture surface. This result was 
subject to a marked inter-donor variability, with conditioned 
media generated by both MSC-1 and MSC-3 resulting in a 
significantly greater degree of EaHy-926 endothelial cell 
spreading than that generated by MSC-2 (Figure 2a, 2b). 
EaHy-926 endothelial cell adherence on fibronectin coated 
plates was most advanced after two hours, compared to 
plates coated in either type I collagen or with                           
decorin (Figure 3). On type I collagen-coated plates, the 
presence of MSC-CM appeared to enhance the rate of EaHy-
926 endothelial cell migration into scratch-wounds compared 
to unconditioned media (Figure 4a, left). EaHy-926 
endothelial cells in MSC-CM closed scratch-wounds to a 
significantly greater degree than those in unconditioned 
media over a 12-hour time course (Figure 4b, left). Once 
again, the degree of this MSC-CM mediated enhancement of 
EaHy-926 endothelial cell migration was subject to inter-
donor variability. Conditioned medium generated by MSC-1 
(and MSC-3) elicited a greater degree of scratch-wound 
closure than MSC-2 over 12 hours (Figure 4b, left). 
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Figure 1 Cells isolated from bone marrow meet the minimum criteria for identification as MSC. Cells are immunoreactive for CD73, 
CD90 and CD105, whilst lacking immunoreactivity for CD14, CD34 and CD45, as shown by histograms obtained by flow cytometry, and readily 
differentiate to form osteoblasts, adipocytes and chondrocytes in vitro. Representative phase contrast images are shown of cells following tri-
lineage differentiation and staining with alkaline phosphotase, oil red O, and toluidine blue (top, left to right). Scale bars = 50µm. 
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Figure 2 MSC-CM coating of culture plates influences EaHy-926 
endothelial cell adherence and spreading. A: MSC-CM coating of 
culture plates influences EaHy-926 endothelial cell adherence and 
spreading. After 4 hours in culture EaHy-926 endothelial cells were 
observably more spread on culture plates coated with MSC-CM than on 
plates coated with unconditioned (control) medium. Representative phase 
contrast images are shown of EaHy-926 endothelial cells 4 hours post 
seeding. B: After 4 hours in culture the average cell area was significantly 
greater for EaHy-926 endothelial cells on MSC-CM coated culture plates 
and 389µm2 than those cells on unconditioned (control) medium coated 
culture plates. Data shown are means ± SEM in relative units 
(***=p<0.001 Mann Whitney U test). 
 
Figure 3 ECM protein coating of culture plates influences EaHy-926 
endothelial cells adherence and spreading. After 4 hours in culture EaHy-926 
endothelial cells were observably more spread on culture plates coated with 
fibronectin than on plates coated with type I collagen or decorin. Representative 
phase contrast images are shown of EaHy-926 endothelial 4 hours post seeding. 
B: After 4 hours in culture the average cell area was significantly greater for EaHy-
926 endothelial cells on fibronectin compared to those cells on either type I 
collagen or decorin. Data shown are means ± SEM in relative units (**=p<0.01, 
***=p<0.001, Mann Whitney U test). 
 
Figure 4 EaHy-926 endothelial cells closed scratch wounds 
faster in MSC-CM than in unconditioned medium on type I 
collagen, fibronectin, and decorin coated culture plates. A: 
EaHy-926 cells on fibronectin coated culture plates closed scratch 
wounds significantly faster than those on either type I collagen or 
decorin. Representative phase contrast images are shown of 
EaHy-926 scratch assays 12 hours post scratching. B: After 12 
hours EaHy-926 endothelial cells in MSC-CM had closed scratch 
wounds by a significantly greater degree than those in 
unconditioned control medium. 12 hours post-scratching,                   
EaHy-926 endothelial cells on plates coated fibronectin had 
closed scratch wounds by a significantly greater degree than 
those on either type I collagen or decorin. On fibronectin and 
decorin, medium conditioned by MSC-2 was associated with 
significantly reduced scratch closure compared to either MSC-1 or 
MSC-3. On type one collagen, medium conditioned by MSC-2 was 
associated with significantly reduced scratch closure compared to 
MSC-1. Data shown are means ± SEM. (* = p<0.05 by Mann 
Whitney U test). 
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These MSC-CM were examined by MALDI/TOF/TOF mass 
spectrometry. All three were found to contain fibronectin, 
collagen type I, collagen type VI, and lumican, whilst cartilage 
oligomeric matrix protein (COMP) and SPARC were present 
in two out of three MSC-CM and laminin, decorin, heparan 
sulphate proteoglycan (HSPG) and IGFBP-1 were each only 
observed in one MSC-CM (Table 1). Of these, decorin, along 
with HSPG were only present in medium conditioned using 
MSC-2. Hence, not only was there clear inter-donor 
variability in the ECM components of the MSC secretome, 
but the presence of these proteoglycans seemed to be 
associated with a reduction in the efficacy of MSC-CM. 
 
When type I collagen, decorin and fibronectin were used as 
culture substrata, the degree of EaHy-926 endothelial cell 
spreading  appeared  to  be  similar upon both type I collagen 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
 
We have previously shown that MSC-CM promotes the 
migration of skin cells in a wound healing model, and 
identified numerous potentially beneficial factors that may 
contribute to this effect. In vivo wound healing is, however, a 
complex process influenced by a host of cellular events, 
including angiogenesis. If MSC can stimulate endothelial 
cells as suggested here and elsewhere
[7]
 this supports their 
potential use in the treatment of cutaneous wounds.  
 
In these experiments, MSC-CM was found to be stimulatory 
to endothelial cell migration in vitro. This is similar to previous 
 
 
and decorin and greatly enhanced upon fibronectin (Figure 
2a, 2b). 
 
Similarly, scratch-wound closure by EaHy-926 endothelial 
cells in unconditioned media appeared to be similar upon 
type I collagen and decorin, but markedly greater upon 
fibronectin (Figure 4a, 4b). In the presence of each ECM 
substrate the presence of MSC-CM resulted in significantly 
enhanced scratch wound closure compared to unconditioned 
media (Figure 4b). As seen previously upon type I collagen 
coated culture plates, the degree of closure upon both 
decorin and fibronectin coated plates was either significantly 
or near significantly (p=0.057 by Mann Whitney U test) less 
in the presence of medium conditioned by MSC-2, compared 
to medium conditioned by either MSC-1 or MSC-3 (Figure 
4b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
studies in which MSC-CM has been shown to stimulate 
angiogenesis
[7]
, supporting the investigation of MSC-CM as a 
pro-angiogenic agent. Although it is possible for proliferation 
of EaHy-926 endothelial cells to have contributed somewhat 
to the closure of the scratch wounds, these scratch assay 
experiments were performed over the course of 12 hours. 
The reported doubling time for these cells is over                                
25 hours
[15]
. To significantly affect the rate of scratch wound 
closure, those cells at the leading edge of the scratch 
margins would be required to undergo repeated doublings, 
and this is unlikely to have had a major influence on scratch 
wound closure over the time course of these studies. 
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Table 1: EXTRACELLULAR MATRIX PROTEINS DETECTED IN MSC 
CONDITIONED MEDIUM USING (MALDI-TOF/TOF) MASS SPECTROMETRY 
MSC-CM 1 MSC-CM 2 MSC-CM 3 
Fibronectin Fibronectin Fibronectin 
Type I Collagen Type I Collagen Type I Collagen 
Type VI Collagen Type VI Collagen Type VI Collagen 
Laminin - - 
COMP  COMP 
Lumican Lumican Lumican 
- Decorin - 
- HSPG - 
SPARC SPARC - 
IGFBP-1 - - 
 
Mass spectrometry of MSC-CM from 3 separate donors. MALDI-TOF/TOF mass spectrometry of MSC-CM detected variable protein 
content between media conditioned by MSC from three different patient donors. 
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Mass spectrometry of MSC-CM revealed numerous factors 
(including fibronectin and collagen) in medium conditioned by 
each of the three MSC examined and some, including 
laminin and decorin, in one or two but not all three of the 
MSC-CM samples. Of these ECM components, fibronectin, 
collagen and laminin are known to promote or support 
angiogenesis
[16]
. Unusually, in these experiments collagen 
did not seem to induce any observable cell response when 
compared to decorin. This result may be elucidated through 
further study. Fibronectin and collagen contain protein motifs 
are known to mediate angiogenesis by integrin receptor 
signaling in vivo and in vitro
[17-19]
. Laminin peptides have also 
been shown to be pro-angiogenic
[20]
. Conversely decorin and 
lumican have been shown to inhibit angiogenesis. Decorin 
inhibits endothelial cell migration and tubule formation in vitro 
[21]
 and inhibits the pro-angiogenic effects of VEGF
[22]
. 
Lumican interferes with α2β1 receptor activity and inhibits 
angiogenesis both in vitro and in vivo
[23, 24]
. Whilst lumican 
was present in each of the MSC-CM used in these 
investigations, decorin was only found within the MSC-CM 
that consistently showed significantly less enhancement of 
EaHy-926 endothelial cell migration. As the method (MALDI-
TOF/TOF mass spectrometry) used to detect these protein 
components within MSC-CM was not quantitative, it was not 
possible to determine whether differences in concentrations 
of each ECM component were related to efficacy of the 
conditioned media. 
 
MSC-CM coating of culture plates enhanced EaHy-926 
endothelial cell adherence, as did coating with fibronectin. 
Cell adherence to these substrata was examined in an 
indirect fashion, by assessing the average area of cells in the 
immediate-early period after seeding. As cells settle upon a 
permissive substrate they spread out from the rounded 
morphology observed in suspension to adopt a flattened 
morphology that is usually seen in vitro in adherent cell 
populations. After prolonged periods of time, cells in culture, 
including endothelial cells, synthesize matrix molecules that 
may also promote cell adhesion, potentially masking the 
initial effects of the original substrate being investigated. Of 
the matrix proteins detected in MSC-CM by MALDI-TOF/TOF 
mass spectrometry, fibronectin was observed to have a 
profound effect upon cell adherence, similar to those findings 
concerning cell migration. 
 
Individually, fibronectin appears contribute to the MSC-CM 
effects observed. However, the addition of MSC-CM to 
endothelial cell scratch assays performed upon fibronectin 
coated culture plates resulted in a further enhancement of 
endothelial cell migration, suggesting that fibronectin may not 
be solely responsible for the entire effect. Further 
experiments investigating the effects of MSC secreted growth 
factors and cytokines individually, and in combination, may 
reveal their relative contribution to the enhancement of 
endothelial cell migration. The relatively low number of 
individual donors examined during this study is a clear 
limitation, and although the results presented support the 
conclusions that (i) MSC donor variation and secretome 
composition may account for differential effects of MSCs on 
endothelial cells, and (ii) that this variation should be taken 
into consideration in MSC-based regenerative medicine, 
subsequent investigation of greater numbers of samples is 
required to further authenticate these findings. 
 
 
 
 
 
 
 
 
Conclusion  
 
Angiogenesis depends on endothelial cell migration and the 
actions of endothelial cell chemotactic factors, e.g. VEGF 
and IL-8
[25-26]
, and ECM proteins such as collagens, 
fibronectin and laminin
[15]
. Many of these pro-angiogenic 
factors have been found to be present within the MSC 
secretome both within this investigation and in previous 
studies
[5]
. These experiments have showed that MSC-CM 
enhances both the rate of endothelial cell migration and the 
adherence of these cells to their culture surface, and that this 
effect was, in part, mediated by the presence of fibronectin. 
Other studies have also highlighted a role for fibronectin in 
stimulating angiogenesis
[16, 17]
. The effects of MSC-CM upon 
endothelial cell migration were not entirely induced by 
fibronectin, as suggested by the further enhancement of 
EaHy-926 endothelial cell migration by MSC-CM in the 
presence of exogenous fibronectin. Factors such as 
Interleukin (IL)-8, VEGF, and laminin have all been shown to 
be stimulatory to endothelial cells
[19, 24]
 and these factors 
have been shown to be present within MSC-CM
[7]
. It seems 
likely that these known mediators of angiogenesis might 
contribute to the effects of MSC-CM upon EaHy926 
endothelial cells observed in these investigations.  
 
Overall, the data presented here support the hypothesis that 
MSC may stimulate the formation of new vasculature, and 
that this may be an important aspect of MSC-mediated 
enhancement of wound healing. 
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